Transaminase concentrations cannot separate non-alcoholic fatty liver and non-alcoholic steatohepatitis in morbidly obese patients irrespective of histological algorithm
- \(\bf Background:\) In current general practice, elevated serum concentrations of liver enzymes are still regarded as an indicator of non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH). In this study, we analyzed if an adjustment of the upper limit of normal (ULN) for serum liver enzymes can improve their diagnostic accuracy. \(\bf Methods:\) Data from 363 morbidly obese patients (42.5 \(\pm\) 10.3 years old; mean BMI: 52 \(\pm\) 8.5 kg/m\(^{2}\)), who underwent bariatric surgery, was retrospectively analyzed. NAFL and NASH were defined histologically according to non-alcoholic fatty liver activity score (NAS) and according to steatosis activity fibrosis (SAF) score for 2 separate analyses, respectively. \(\bf Results:\) In 121 women (45%) and 45 men (46%), elevated values for at least one serum parameter (ALT, AST, \(\gamma\)GT) were present. The serum concentrations of ALT (\(\it p\) < 0.0001), AST (\(\it p\) < 0.0001) and \(\gamma\)GT (\(\it p\) = 0.0023) differed significantly between NAFL and NASH, irrespective of the applied histological classification method. Concentrations of all 3 serum parameters correlated significantly positively with the NAS and the SAF score, with correlation coefficients between 0.33 (ALT/NAS) and 0.40 (\(\gamma\)GT/SAF). The area under the curves to separate NAFL and NASH by liver enzymes achieved a maximum of 0.70 (ALT applied to NAS-based classification). For 95% specificity, the ULN for ALT would be 47.5 U/L; for 95% sensitivity, the ULN for ALT would be 17.5 U/L, resulting in 62% uncategorized patients. \(\bf Conclusion:\) ALT, AST, and γGT are unsuitable for non-invasive screening or diagnosis of NAFL or NASH. Utilizing liver enzymes as an indicator for NAFLD or NASH should generally be questioned.
Author: | Peter LemmerGND, Nicole SelbachGND, Theodor BaarsGND, Mustafa Porsch-ÖzcürümezORCiDGND, Dominik HeiderORCiDGND, Ali E. CanbayORCiDGND, Jan-Peter SowaORCiDGND |
---|---|
URN: | urn:nbn:de:hbz:294-93916 |
DOI: | https://doi.org/10.1159/000519317 |
Parent Title (German): | Digestive diseases |
Publisher: | Karger |
Place of publication: | Basel |
Document Type: | Article |
Language: | English |
Date of Publication (online): | 2022/10/27 |
Date of first Publication: | 2021/09/01 |
Publishing Institution: | Ruhr-Universität Bochum, Universitätsbibliothek |
Tag: | Alanine-aminotransferase; Aspartate-aminotransferase; Gamma-glutamyltransferase; Liver; Liver enzymes; NAFLD; NAFLD activity Score; Non-invasive prediction; Obesity; SAF score |
Volume: | 40 |
Issue: | 5 |
First Page: | 644 |
Last Page: | 653 |
Note: | Dieser Beitrag ist aufgrund einer konsortialen Lizenz frei zugänglich. |
Institutes/Facilities: | Knappschaftskrankenhaus Bochum, Medizinische Klinik |
Dewey Decimal Classification: | Technik, Medizin, angewandte Wissenschaften / Medizin, Gesundheit |
open_access (DINI-Set): | open_access |
Licence (German): | Konsortiale Lizenz |